Central Real Estate is a real estate holding company founded by Swiss pension funds, investment foundations and insurance companies. It invests in visionary and sustainable real estate development projects at urban locations in Swiss economic centres.
The Central Real Estate Group subsidiary has acquired a development site of approximately 160,000m2 in Basel’s Klybeck Quarter from Novartis Pharma AG. An attractive urban space for living, working, leisure and culture will be built here in the coming years.